These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27668155)

  • 21. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.
    López-Cabrera M; Aguilera A; Aroeira LS; Ramírez-Huesca M; Pérez-Lozano ML; Jiménez-Heffernan JA; Bajo MA; del Peso G; Sánchez-Tomero JA; Selgas R
    Perit Dial Int; 2006; 26(1):26-34. PubMed ID: 16538870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The transcription factor scleraxis is a critical regulator of cardiac fibroblast phenotype.
    Bagchi RA; Roche P; Aroutiounova N; Espira L; Abrenica B; Schweitzer R; Czubryt MP
    BMC Biol; 2016 Mar; 14():21. PubMed ID: 26988708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diverse origins of the myofibroblast—implications for kidney fibrosis.
    Falke LL; Gholizadeh S; Goldschmeding R; Kok RJ; Nguyen TQ
    Nat Rev Nephrol; 2015 Apr; 11(4):233-44. PubMed ID: 25584804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients.
    Aguilera A; Yáñez-Mo M; Selgas R; Sánchez-Madrid F; López-Cabrera M
    Curr Opin Investig Drugs; 2005 Mar; 6(3):262-8. PubMed ID: 15816502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model.
    Yoshio Y; Miyazaki M; Abe K; Nishino T; Furusu A; Mizuta Y; Harada T; Ozono Y; Koji T; Kohno S
    Kidney Int; 2004 Oct; 66(4):1677-85. PubMed ID: 15458466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis.
    Bijkerk R; Au YW; Stam W; Duijs JMGJ; Koudijs A; Lievers E; Rabelink TJ; van Zonneveld AJ
    Front Pharmacol; 2019; 10():215. PubMed ID: 30914951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.
    Fan YP; Hsia CC; Tseng KW; Liao CK; Fu TW; Ko TL; Chiu MM; Shih YH; Huang PY; Chiang YC; Yang CC; Fu YS
    Stem Cells Transl Med; 2016 Feb; 5(2):235-47. PubMed ID: 26718649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition.
    Quaggin SE; Kapus A
    Kidney Int; 2011 Jul; 80(1):41-50. PubMed ID: 21430641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-200a negatively regulates TGF-β
    Guo R; Hao G; Bao Y; Xiao J; Zhan X; Shi X; Luo L; Zhou J; Chen Q; Wei X
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1087-F1095. PubMed ID: 29357421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HL156A, a novel AMP-activated protein kinase activator, is protective against peritoneal fibrosis in an in vivo and in vitro model of peritoneal fibrosis.
    Ju KD; Kim HJ; Tsogbadrakh B; Lee J; Ryu H; Cho EJ; Hwang YH; Kim K; Yang J; Ahn C; Oh KH
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F342-50. PubMed ID: 26661649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast.
    Gharaee-Kermani M; Hu B; Phan SH; Gyetko MR
    Curr Med Chem; 2009; 16(11):1400-17. PubMed ID: 19355895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis.
    Wu J; Xing C; Zhang L; Mao H; Chen X; Liang M; Wang F; Ren H; Cui H; Jiang A; Wang Z; Zou M; Ji Y
    J Cell Mol Med; 2018 Feb; 22(2):1190-1201. PubMed ID: 29077259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of CIP4 in high glucose induced epithelial--mesenchymal transition of rat peritoneal mesothelial cells.
    Zhang J; Bi M; Zhong F; Jiao X; Zhang D; Dong Q
    Ren Fail; 2013 Aug; 35(7):989-95. PubMed ID: 23819628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial-mesenchymal transition: An emerging target in tissue fibrosis.
    Li M; Luan F; Zhao Y; Hao H; Zhou Y; Han W; Fu X
    Exp Biol Med (Maywood); 2016 Jan; 241(1):1-13. PubMed ID: 26361988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selenium suppresses lipopolysaccharide-induced fibrosis in peritoneal mesothelial cells through inhibition of epithelial-to-mesenchymal transition.
    Liu J; Zeng L; Zhao Y; Zhu B; Ren W; Wu C
    Biol Trace Elem Res; 2014 Nov; 161(2):202-9. PubMed ID: 25108639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT?
    Radisky DC; Kenny PA; Bissell MJ
    J Cell Biochem; 2007 Jul; 101(4):830-9. PubMed ID: 17211838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Src attenuates peritoneal fibrosis and inhibits the epithelial to mesenchymal transition.
    Wang J; Wang L; Xu L; Shi Y; Liu F; Qi H; Liu N; Zhuang S
    Oncotarget; 2017 Oct; 8(48):83872-83889. PubMed ID: 29137389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peritoneal Dialysis Vintage and Glucose Exposure but Not Peritonitis Episodes Drive Peritoneal Membrane Transformation During the First Years of PD.
    Bartosova M; Schaefer B; Vondrak K; Sallay P; Taylan C; Cerkauskiene R; Dzierzega M; Milosevski-Lomic G; Büscher R; Zaloszyc A; Romero P; Lasitschka F; Warady BA; Schaefer F; Ujszaszi A; Schmitt CP
    Front Physiol; 2019; 10():356. PubMed ID: 31001140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum.
    Margetts PJ; Bonniaud P; Liu L; Hoff CM; Holmes CJ; West-Mays JA; Kelly MM
    J Am Soc Nephrol; 2005 Feb; 16(2):425-36. PubMed ID: 15590759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1,25-Dihydroxyvitamin D3 Prevents Epithelial-Mesenchymal Transition of HMrSV5 Human Peritoneal Mesothelial Cells by Inhibiting Histone Deacetylase 3 (HDAC3) and Increasing Vitamin D Receptor (VDR) Expression Through the Wnt/β-Catenin Signaling Pathway.
    Liu KH; Fu J; Zhou N; Yin W; Yang YY; Ouyang SX; Liang YM
    Med Sci Monit; 2019 Aug; 25():5892-5902. PubMed ID: 31391414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.